Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

 News

Pink october : The Printemps study for an improved approach to fatigue

Press release (27/10/2022)  A programme to favour faster and more lasting rehabilitation for breast cancer patients 27 October 2022 – At the Jules Bordet Institute, improving knowledge of quality of life is inseparable from quality of care. This is why the first patient has joined the Printemps [Spring] study. This pilot project for a multidisciplinary approach to the fatigue experienced after breast cancer or a germ cell tumour in…
(read more)

Pink October : The MyPeBS study

Press release (20/10/2022)  The MyPeBS Study : « Advancing knowledge about breast cancer screening is essential» October 20, 2022 – MyPeBS (My Personal Breast Cancer Screening) is a clinical study which aims to evaluate a breast cancer screening strategy based on individual risk. The clinical study, coordinated by Unicancer (France) involves 28 partners in 6 countries (Belgium, France, Italy, United Kingdom, Israel, Spain). In Belgium it…
(read more)

Octobre rose - Les facteurs de risque du cancer du sein 

News publiée le 18/10/2022 Octobre rose - Les facteurs de risque du cancer du sein  Il existe des facteurs de risque du cancer du sein sur lesquels on ne peut PAS agir, tels que l’âge, les mutations génétiques (gênes de type BRCA1 and BRCA2), l’histoire reproductive (avoir ses règles avant 12 ans et ménopause au-delà de 55 ans expose à davantage de variations hormonales), avoir des seins d’une densité importante, votre propre histoire…
(read more)

The Bordet Institute's Anatomical Pathology Department acquires a latest generation slide scanner

14/10/2022 The Bordet Institute's Anatomical Pathology Department acquires a latest generation slide scanner Thanks to funding of more than 105,000 euros from the Jules Bordet Association, the Institute's Anatomical Pathology Department recently acquired a latest generation histological slide scanner. This acquisition will enrich the department's digital pathology platform as it commits further to the pursuit of its triple mission of care…
(read more)

Breast cancer and fertility

Press release (11/10/2022)  Breast cancer and fertility
Progress in research is bringing great hope to women who want to have children Pink October is breast cancer awareness month. On this occasion, the Jules Bordet Institute is looking at links between breast cancer and fertility. Given the increase in breast cancers and the fact that women want to have children later and later in life, cases of patients diagnosed with breast…
(read more)

Pink October, a month à breast cancer awareness

Press Release (30/09/2022)  PINK OCTOBER, A MONTH OF BREAST CANCER AWARENESSToday more than ever, the Hôpital Universitaire de Bruxelles (H.U.B) is supporting the fight against breast cancer 30/09/2022 - Breast cancer affects more than 10,000 women a year in Belgium, making it the number one cause of death among women. The Hôpital Universitaire de Bruxelles, consisting of the Jules Bordet Institute, the Erasmus Hospital and the Queen…
(read more)

15 September, Lymphoma Awareness Day

15/09/2022 15 September, Lymphoma Awareness Day Lymphoma is a cancer of the immune system with around 1,250 new cases diagnosed every year in Belgium. This includes people of all ages, both children and adults. The multidisciplinary teams from the Haematology Departments at the Brussels University Hospital (Jules Bordet Institute, the Queen Fabiola Children's University Hospital and the Erasmus Hospital) provide personalised care for each…
(read more)

July: Sarcoma awareness month

News publiée le 12/07/2022 July: Sarcoma awareness month On the occasion of sarcoma awareness month, the Jules Bordet Institute is taking a look at the specific characteristics of these rare tumours that affect nearly 600 people a year in Belgium.    Sarcoma: a rare tumour that affects the bones or tissue  
Sarcomas are rare tumours that develop in the bones and in the conjunctive tissue that supports other body tissue…
(read more)

The I-SPARC study

News :13/06/2022 Do you want to contribute to research to combat the Coronavirus (COVID-19) among cancer patients? The I-SPARC study
The I-SPARC clinical trial aims to evaluate the immune response among cancer patients after administering at least two doses and possibly a booster dose of an RNA messenger vaccine against COVID-19 (Pfizer/BioNTech vaccine or Moderna vaccine).*    This international clinical trial is being…
(read more)

Reopening of Bordet’n Family

News : 09/06/2022 Reopening of Bordet’n Family The Psycho-Oncology Clinic is pleased to announce the reopening of its reception area on Wednesday afternoons.  A place where families facing cancer can come together to be heard and interact with others.   The arrival of cancer and cancer treatment can be very disturbing for families. When faced with the illness of a close family member, children and adolescents can experience…
(read more)